HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- pyroglutamyl- epsilon- palmitoyllysyl(16)- glucose-dependent insulinotropic polypeptide

may prove useful in diabetes 2 therapy
Also Known As:
glucose-dependent insulinotropic polypeptide, N-pyroglutamyl-epsilon-palmitoyllysyl(16)-; pGluGIP(LysPAL(16))
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results